Wells Fargo & Company Raises Church & Dwight (NYSE:CHD) Price Target to $115.00

Church & Dwight (NYSE:CHD) had its price objective hoisted by equities research analysts at Wells Fargo & Company from $113.00 to $115.00 in a research note issued on Monday, Benzinga reports. The firm currently has an “overweight” rating on the stock. Wells Fargo & Company‘s price target would suggest a potential upside of 10.44% from the stock’s current price.

CHD has been the subject of a number of other reports. JPMorgan Chase & Co. lifted their target price on Church & Dwight from $97.00 to $98.00 and gave the company an “underweight” rating in a research note on Friday, October 11th. Stifel Nicolaus lowered their price objective on Church & Dwight from $107.00 to $105.00 and set a “hold” rating for the company in a research note on Monday, August 5th. Evercore ISI cut their target price on Church & Dwight from $110.00 to $101.00 and set an “in-line” rating on the stock in a research note on Monday, August 5th. Truist Financial reduced their price target on shares of Church & Dwight from $115.00 to $110.00 and set a “buy” rating for the company in a report on Monday, August 5th. Finally, TD Cowen began coverage on shares of Church & Dwight in a report on Tuesday, July 23rd. They issued a “buy” rating and a $116.00 price objective on the stock. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $108.05.

Church & Dwight Price Performance

Shares of NYSE CHD opened at $104.13 on Monday. The business has a 50 day simple moving average of $102.98 and a 200-day simple moving average of $104.03. Church & Dwight has a twelve month low of $86.23 and a twelve month high of $110.31. The company has a market capitalization of $25.49 billion, a price-to-earnings ratio of 46.70, a price-to-earnings-growth ratio of 3.87 and a beta of 0.55. The company has a current ratio of 1.62, a quick ratio of 1.09 and a debt-to-equity ratio of 0.53.

Church & Dwight (NYSE:CHD) last issued its earnings results on Friday, November 1st. The company reported $0.79 earnings per share for the quarter, topping analysts’ consensus estimates of $0.68 by $0.11. Church & Dwight had a net margin of 9.08% and a return on equity of 19.90%. The company had revenue of $1.51 billion for the quarter, compared to analysts’ expectations of $1.50 billion. During the same period in the prior year, the company earned $0.74 earnings per share. The firm’s revenue was up 3.8% compared to the same quarter last year. As a group, equities research analysts expect that Church & Dwight will post 3.43 earnings per share for the current year.

Insider Activity

In related news, Director Arthur B. Winkleblack sold 11,590 shares of Church & Dwight stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $103.84, for a total transaction of $1,203,505.60. Following the transaction, the director now directly owns 7,129 shares of the company’s stock, valued at $740,275.36. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CEO Matthew Farrell sold 165,823 shares of the stock in a transaction on Monday, November 4th. The stock was sold at an average price of $103.03, for a total transaction of $17,084,743.69. Following the completion of the sale, the chief executive officer now owns 112,719 shares in the company, valued at approximately $11,613,438.57. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Arthur B. Winkleblack sold 11,590 shares of Church & Dwight stock in a transaction on Monday, November 4th. The stock was sold at an average price of $103.84, for a total value of $1,203,505.60. Following the completion of the transaction, the director now owns 7,129 shares in the company, valued at $740,275.36. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.40% of the company’s stock.

Hedge Funds Weigh In On Church & Dwight

Hedge funds and other institutional investors have recently modified their holdings of the stock. Capital Performance Advisors LLP acquired a new position in shares of Church & Dwight in the third quarter worth about $27,000. Crewe Advisors LLC acquired a new position in Church & Dwight in the 1st quarter worth approximately $28,000. Ashton Thomas Securities LLC acquired a new position in Church & Dwight in the 3rd quarter worth approximately $28,000. Rothschild Investment LLC purchased a new position in Church & Dwight during the 2nd quarter worth approximately $31,000. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in Church & Dwight during the 2nd quarter valued at $33,000. Institutional investors and hedge funds own 86.60% of the company’s stock.

About Church & Dwight

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.